Bayer Seeks FDA and China CDE Approval for Finerenone in Heart Failure Treatment
Bayer Seeks FDA and China CDE Approval for Finerenone in Heart Failure Treatment Bayer has recently submitted marketing authorization applications for its drug finerenone to both the U.S. Food and Drug Administration (FDA) and the Center for Drug Evaluation (CDE)…